Apellis Pharmaceuticals Inc (NASDAQ:APLS) price on Wednesday, May 09, fall -3.64% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $42.30.
A look at the stock’s price movement, the close in the last trading session was $43.90. Turning to its 52-week performance, $94.75 and $19.83 were the 52-week high and 52-week low respectively. Overall, APLS moved -23.26% over the past month.
Apellis Pharmaceuticals Inc’s market cap currently stands at around $5.13 billion.
Analysts have a consensus estimate of 190.8M for the company’s revenue for the quarter, with a low and high estimate of 163.8M and 230.15M respectively. The average forecast suggests up to a 171.60% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 809.98M, representing a 104.20% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that APLS is a 100% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
APLS’s current price about -13.72% and -23.02% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 32.88, while 7-day volatility ratio is 6.19% and 6.42% in the 30-day chart. Further, Apellis Pharmaceuticals Inc (APLS) has a beta value of 0.98, and an average true range (ATR) of 3.12.
If we refocus on Apellis Pharmaceuticals Inc (NASDAQ:APLS), historical trading data shows that trading volumes averaged 1.48 million over the past 3 months. The company’s latest data on shares outstanding shows there are 119.56 million shares.
The 18.03% of Apellis Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 91.20% of the company’s shares. Current price change has pushed the stock -29.34% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the APLS stock continues to rise going into the next quarter.
